Novo Nordisk veteran takes up CMO position at Danish-Swedish biotech company

Anders Dyhr Toft, who has worked for Novo Nordisk for many years, will step into the role of CMO at SynAct Pharma on Aug. 1.
Synact Pharma CEO Jeppe Øvlesen | Photo: Synact Pharma / PR
Synact Pharma CEO Jeppe Øvlesen | Photo: Synact Pharma / PR
BY ANDREAS LØNSTRUP, TRANSLATED BY NIELSINE NIELSEN

On Wednesday, SynAct Pharma appointed Anders Dyhr Toft as its Chief Medical Officer (CMO). This will come into effect on Aug. 1, according to a company press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading